“PLCE1 is a poor prognostic marker and may promote immune escape from osteosarcoma by the CD70-CD27 signaling pathway” (2022) Biomolecules and Biomedicine, 22(6), pp. 992–1004. doi:10.17305/bjbms.2022.7416.